RAPT Therapeutics, Inc. Financing Cash Flow
RAPT Therapeutics, Inc. reported Financing Cash Flow of $197.00 thousand for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2025-11-06
- RAPT Therapeutics, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $36.00K.
- RAPT Therapeutics, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-06-30 was $161.00K, a 77.03% decline year-over-year.
- RAPT Therapeutics, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- RAPT Therapeutics, Inc. net cash provided by (used in) financing activities for the quarter ending 2024-12-31 was $143.12M, a 31147.82% increase year-over-year.
- RAPT Therapeutics, Inc. net cash provided by (used in) financing activities for fiscal 2024 was $152.85M, a 10463.37% increase from fiscal 2023.
- RAPT Therapeutics, Inc. net cash provided by (used in) financing activities for fiscal 2023 was $1.45M, a 98.90% decline from fiscal 2022.
- RAPT Therapeutics, Inc. net cash provided by (used in) financing activities for fiscal 2022 was $131.18M, a 7.28% decline from fiscal 2021.
- RAPT Therapeutics, Inc. net cash provided by (used in) financing activities for fiscal 2021 was $141.48M, a 87.49% increase from fiscal 2020.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2025-09-30 | $36.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $197.00K derived: sum of 2 quarters · filed 2025-11-06 | $197.00K 10-Q · filed 2025-11-06 | $143.31M derived: sum of 4 quarters · filed 2025-11-06 |
| 2025-06-30 | $161.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $161.00K 10-Q · filed 2025-08-07 | $143.28M derived: sum of 3 quarters · filed 2025-08-07 | $143.28M derived: sum of 4 quarters · filed 2025-11-06 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-08 | $143.12M derived: sum of 2 quarters · filed 2025-05-08 | $143.12M derived: sum of 3 quarters · filed 2025-11-06 | $143.82M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-12-31 | $143.12M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $143.12M derived: sum of 2 quarters · filed 2025-11-06 | $143.82M derived: sum of 3 quarters · filed 2025-11-06 | $152.85M 10-K · filed 2025-03-06 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $701.00K derived: sum of 2 quarters · filed 2025-11-06 | $9.74M 10-Q · filed 2025-11-06 | $10.20M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $701.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $9.74M 10-Q · filed 2025-08-07 | $10.20M derived: sum of 3 quarters · filed 2025-08-07 | $10.30M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $9.04M 10-Q · filed 2025-05-08 | $9.49M derived: sum of 2 quarters · filed 2025-05-08 | $9.60M derived: sum of 3 quarters · filed 2025-05-08 | $10.37M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $458.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $564.00K derived: sum of 2 quarters · filed 2025-03-06 | $1.33M derived: sum of 3 quarters · filed 2025-03-06 | $1.45M 10-K · filed 2025-03-06 |
| 2023-09-30 | $106.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $873.00K derived: sum of 2 quarters · filed 2024-11-12 | $989.00K 10-Q · filed 2024-11-12 | $76.35M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $767.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $883.00K 10-Q · filed 2024-08-08 | $76.24M derived: sum of 3 quarters · filed 2024-08-08 | $81.49M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $116.00K 10-Q · filed 2024-05-09 | $75.47M derived: sum of 2 quarters · filed 2024-05-09 | $80.73M derived: sum of 3 quarters · filed 2024-05-09 | $131.16M derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $75.36M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $80.61M derived: sum of 2 quarters · filed 2024-03-07 | $131.05M derived: sum of 3 quarters · filed 2024-03-07 | $131.18M 10-K · filed 2024-03-07 |
| 2022-09-30 | $5.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $55.69M derived: sum of 2 quarters · filed 2023-11-13 | $55.82M 10-Q · filed 2023-11-13 | $56.42M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $50.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $50.57M 10-Q · filed 2023-08-11 | $51.17M derived: sum of 3 quarters · filed 2023-08-11 | $51.64M derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | $132.00K 10-Q · filed 2023-05-11 | $733.00K derived: sum of 2 quarters · filed 2023-05-11 | $1.21M derived: sum of 3 quarters · filed 2023-05-11 | $140.31M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $601.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $1.07M derived: sum of 2 quarters · filed 2023-03-14 | $140.18M derived: sum of 3 quarters · filed 2023-03-14 | $141.48M 10-K · filed 2023-03-14 |
| 2021-09-30 | $472.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $139.58M derived: sum of 2 quarters · filed 2022-11-10 | $140.88M 10-Q · filed 2022-11-10 | $145.44M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $139.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $140.41M 10-Q · filed 2022-08-11 | $144.97M derived: sum of 3 quarters · filed 2022-08-11 | $145.13M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $1.30M 10-Q · filed 2022-05-11 | $5.86M derived: sum of 2 quarters · filed 2022-05-11 | $6.03M derived: sum of 3 quarters · filed 2022-05-11 | $6.89M derived: sum of 4 quarters · filed 2022-05-11 |
| 2020-12-31 | $4.56M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $4.72M derived: sum of 2 quarters · filed 2022-03-10 | $5.59M derived: sum of 3 quarters · filed 2022-03-10 | $75.46M 10-K · filed 2022-03-10 |
| 2020-09-30 | $165.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $1.03M derived: sum of 2 quarters · filed 2021-11-10 | $70.90M 10-Q · filed 2021-11-10 | $105.64M derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $864.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $70.74M 10-Q · filed 2021-08-11 | $105.48M derived: sum of 3 quarters · filed 2021-08-11 | $106.14M derived: sum of 4 quarters · filed 2021-08-11 |
| 2020-03-31 | $69.87M 10-Q · filed 2021-05-11 | $104.61M derived: sum of 2 quarters · filed 2021-05-11 | $105.28M derived: sum of 3 quarters · filed 2021-05-11 | $112.76M derived: sum of 4 quarters · filed 2021-05-11 |
| 2019-12-31 | $34.74M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $35.40M derived: sum of 2 quarters · filed 2021-03-11 | $42.89M derived: sum of 3 quarters · filed 2021-03-11 | $49.90M 10-K · filed 2021-03-11 |
| 2019-09-30 | $663.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $8.15M derived: sum of 2 quarters · filed 2020-11-16 | $15.16M 10-Q · filed 2020-11-16 | $37.78M derived: sum of 4 quarters · filed 2020-11-16 |
| 2019-06-30 | $7.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | $14.50M 10-Q · filed 2020-08-13 | $37.12M derived: sum of 3 quarters · filed 2020-08-13 | |
| 2019-03-31 | $7.01M 10-Q · filed 2020-05-14 | $29.64M derived: sum of 2 quarters · filed 2020-05-14 | ||
| 2018-12-31 | $22.62M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $52.73M 10-K · filed 2020-03-30 | ||
| 2018-09-30 | $30.11M 10-Q · filed 2019-12-11 |